The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.o

Vascultis (pulmonary, extrathoracic or systemic)-ANCA status unknown or negative)

Publications

Gilio M, De Stefano G

Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine.

Internal and emergency medicine 2022 Jan 24;; — 2022 Jan 24

Bostan E, Zaid F, Akdogan N, Gokoz O

Possible case of mRNA COVID-19 vaccine-induced small-vessel vasculitis.

Journal of cosmetic dermatology 2021 Oct 27;; — 2021 Oct 27

Gillion V, Jadoul M, Demoulin N, Aydin S, Devresse A

Granulomatous vasculitis after the Astra-Zeneca anti-SARS-CoV-2 vaccine.

Kidney international 2021 Jul 05;; — 2021 Jul 05